{
     "PMID": "1360641",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19930106",
     "LR": "20141120",
     "IS": "0304-3940 (Print) 0304-3940 (Linking)",
     "VI": "142",
     "IP": "2",
     "DP": "1992 Aug 17",
     "TI": "Norepinephrine reverses N-methyl-D-aspartate-mediated inhibition of long-term potentiation in rat hippocampal slices.",
     "PG": "163-6",
     "AB": "Application of 1 microM N-methyl-D-aspartate (NMDA) either immediately before or following tetanic stimulation inhibits the induction of CA1 hippocampal long-term potentiation (LTP). We have examined the effect of trans-amino-1,3-cyclopentanedicarboxylic acid (ACPD), norepinephrine and acetylcholine on this NMDA-mediated LTP inhibition using extracellular recordings from in vitro rat hippocampal slices. When NMDA is accompanied by 100 microM ACPD or 10 microM norepinephrine, the block of LTP is overcome. The norepinephrine effect is mimicked by phenylephrine and methoxamine and is blocked by phentolamine and prazosin suggesting the involvement of alpha 1-adrenergic receptors.",
     "FAU": [
          "Izumi, Y",
          "Clifford, D B",
          "Zorumski, C F"
     ],
     "AU": [
          "Izumi Y",
          "Clifford DB",
          "Zorumski CF"
     ],
     "AD": "Department of Psychiatry, Washington University Medical School, St. Louis, MO 63110.",
     "LA": [
          "eng"
     ],
     "GR": [
          "AG05681/AG/NIA NIH HHS/United States",
          "MH00630/MH/NIMH NIH HHS/United States",
          "MH45493/MH/NIMH NIH HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't",
          "Research Support, U.S. Gov't, P.H.S."
     ],
     "PL": "Ireland",
     "TA": "Neurosci Lett",
     "JT": "Neuroscience letters",
     "JID": "7600130",
     "RN": [
          "0 (Adrenergic alpha-Antagonists)",
          "0 (Adrenergic beta-Antagonists)",
          "0TQU7668EI (Cycloleucine)",
          "111900-32-4 (1-amino-1,3-dicarboxycyclopentane)",
          "1WS297W6MV (Phenylephrine)",
          "6384-92-5 (N-Methylaspartate)",
          "HUQ1KC1YLI (Methoxamine)",
          "L628TT009W (Isoproterenol)",
          "X4W3ENH1CV (Norepinephrine)"
     ],
     "SB": "IM",
     "MH": [
          "Adrenergic alpha-Antagonists/pharmacology",
          "Adrenergic beta-Antagonists/pharmacology",
          "Animals",
          "Cycloleucine/analogs & derivatives/pharmacology",
          "Hippocampus/drug effects/*metabolism",
          "In Vitro Techniques",
          "Isoproterenol/pharmacology",
          "Male",
          "Methoxamine/pharmacology",
          "N-Methylaspartate/*antagonists & inhibitors/pharmacology",
          "Neuronal Plasticity/*drug effects",
          "Norepinephrine/antagonists & inhibitors/*pharmacology",
          "Phenylephrine/pharmacology",
          "Rats"
     ],
     "EDAT": "1992/08/17 00:00",
     "MHDA": "1992/08/17 00:01",
     "CRDT": [
          "1992/08/17 00:00"
     ],
     "PHST": [
          "1992/08/17 00:00 [pubmed]",
          "1992/08/17 00:01 [medline]",
          "1992/08/17 00:00 [entrez]"
     ],
     "AID": [
          "0304-3940(92)90364-D [pii]"
     ],
     "PST": "ppublish",
     "SO": "Neurosci Lett. 1992 Aug 17;142(2):163-6.",
     "term": "hippocampus"
}